PKM and non-small cell lung carcinoma: In this study, the transfer of pY105-PKM2 via sEVs to recipient cells induced slower cell cycle progression, metabolic remodeling, and enhanced chemoresistance, highlighting the mechanisms underlying CSC resilience and the recurrence often seen in NSCLC.